Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts

  • alyse_c
    replied
    Tomorrow is the last day to submit your results for the NCTR Indel Calling from Oncopanel Sequencing Data Challenge! Phase 1 closes on July 8th. The optional Phase 2 is open for only those who have completed Phase 1 and will run from July 11th-July 26th.

    Submit your results here: https://go.usa.gov/xSc6t


    Originally posted by alyse_c View Post
    There are only a few days left to submit your results for the NCTR Indel Calling from Oncopanel Sequencing Data Challenge! Phase 1 closes on July 8th. Those who completed Phase 1 for both Oncopanel A & Oncopanel B will be able to participate in the optional Phase 2 that runs from July 11th-July 26th.

    Visit the site below to submit your final results!
    https://go.usa.gov/xJzdB



    Leave a comment:


  • alyse_c
    replied
    There are only a few days left to submit your results for the NCTR Indel Calling from Oncopanel Sequencing Data Challenge! Phase 1 closes on July 8th. Those who completed Phase 1 for both Oncopanel A & Oncopanel B will be able to participate in the optional Phase 2 that runs from July 11th-July 26th.

    Visit the site below to submit your final results!
    https://go.usa.gov/xJzdB


    Originally posted by alyse_c View Post
    Reminder! We are less than one month out from the NCTR Indel Calling from Oncopanel Sequencing Data Challenge submission deadline! There’s still time to join the challenge.

    This challenge is being hosted in collaboration with the FDA’s National Center for Toxicological Research (NCTR) and is taking part in two phases.

    Phase 1 of the challenge will run through July 8th and Phase 2 will run from July 11th-July 26th.

    The primary goal of this challenge is to encourage the bioinformatics community to develop, validate, and benchmark indel calling pipelines to identify indels in oncopanel sequencing datasets. Given the widely recognized impact of indels on protein coding and function, it is crucial that the tools for indel-calling be rigorously evaluated and optimized.

    Winners of the challenge will be publicly recognized and invited to contribute to a manuscript and a webinar describing the challenge and their submission results. Visit the challenge site below to get started or to submit your results!

    https://go.usa.gov/xJw8B

    Leave a comment:


  • PrecisionFDA's NCTR Indel Calling from Oncopanel Sequencing Data Challenge

    Reminder! We are less than one month out from the NCTR Indel Calling from Oncopanel Sequencing Data Challenge submission deadline! There’s still time to join the challenge.

    This challenge is being hosted in collaboration with the FDA’s National Center for Toxicological Research (NCTR) and is taking part in two phases.

    Phase 1 of the challenge will run through July 8th and Phase 2 will run from July 11th-July 26th.

    The primary goal of this challenge is to encourage the bioinformatics community to develop, validate, and benchmark indel calling pipelines to identify indels in oncopanel sequencing datasets. Given the widely recognized impact of indels on protein coding and function, it is crucial that the tools for indel-calling be rigorously evaluated and optimized.

    Winners of the challenge will be publicly recognized and invited to contribute to a manuscript and a webinar describing the challenge and their submission results. Visit the challenge site below to get started or to submit your results!

    https://go.usa.gov/xJw8B
    Last edited by alyse_c; 06-22-2022, 01:18 PM.

Latest Articles

Collapse

  • SEQadmin2
    16S/ITS Profiling vs. Shotgun Metagenomics: What Changes in Your Workflow?
    by SEQadmin2




    NGS has revolutionized clinical microbiology by offering new ways to identify and surveil pathogens without prior knowledge of the target. One popular approach is 16S rRNA and ITS amplicon sequencing, which targets specific microbial markers. But studies are increasingly incorporating shotgun metagenomics, a technique that sequences all DNA from a sample without targeting specific microbial markers. This approach allows more detailed taxonomic classification, detection...
    Today, 06:46 AM
  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 10-28-2026, 09:57 AM
0 responses
22 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-28-2026, 09:51 AM
0 responses
14 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 11:13 AM
0 responses
68 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 10:48 AM
0 responses
47 views
0 reactions
Last Post SEQadmin2  
Working...